BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35696263)

  • 1. Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
    Zhu R; Jalo E; Silvestre MP; Poppitt SD; Handjieva-Darlenska T; Handjiev S; Huttunen-Lenz M; Mackintosh K; Stratton G; Navas-Carretero S; Pietiläinen KH; Simpson E; Macdonald IA; Muirhead R; Brand-Miller J; Fogelholm M; Færch K; Martinez JA; Westerterp-Plantenga MS; Adam TC; Raben A
    Diabetes Care; 2022 Nov; 45(11):2698-2708. PubMed ID: 35696263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW.
    Zhu R; Craciun I; Bernhards-Werge J; Jalo E; Poppitt SD; Silvestre MP; Huttunen-Lenz M; McNarry MA; Stratton G; Handjiev S; Handjieva-Darlenska T; Navas-Carretero S; Sundvall J; Adam TC; Drummen M; Simpson EJ; Macdonald IA; Brand-Miller J; Muirhead R; Lam T; Vestentoft PS; Færch K; Martinez JA; Fogelholm M; Raben A
    Diabetologia; 2022 Aug; 65(8):1262-1277. PubMed ID: 35610522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between HbA
    P Silvestre M; Fogelholm M; Alves M; Papoila A; Adam T; Liu A; Brand-Miller J; Martinez JA; Westerterp-Plantenga M; Handjieva-Darlenska T; Macdonald IA; Zhu R; Jalo E; Muirhead R; Carretero SN; Handjiev S; Taylor MA; Raben A; Poppitt SD
    Clin Nutr; 2023 May; 42(5):636-643. PubMed ID: 36933350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial.
    Weber MB; Ranjani H; Staimez LR; Anjana RM; Ali MK; Narayan KM; Mohan V
    Diabetes Care; 2016 Oct; 39(10):1760-7. PubMed ID: 27504014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
    Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
    Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.
    Greiner GG; Emmert-Fees KMF; Becker J; Rathmann W; Thorand B; Peters A; Quante AS; Schwettmann L; Laxy M
    Acta Diabetol; 2020 Dec; 57(12):1481-1491. PubMed ID: 32748175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of obesity phenotypes with weight change, cardiometabolic benefits, and type 2 diabetes incidence during a lifestyle intervention: results from the PREVIEW study.
    Zhu R; Huttunen-Lenz M; Stratton G; Handjieva-Darlenska T; Handjiev S; Sundvall J; Silvestre MP; Jalo E; Pietiläinen KH; Adam TC; Drummen M; Simpson EJ; Taylor MA; Poppitt SD; Navas-Carretero S; Martinez JA; Schlicht W; Fogelholm M; Brand-Miller J; Raben A
    Int J Obes (Lond); 2023 Sep; 47(9):833-840. PubMed ID: 37420008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
    Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials.
    Sathish T; Khunti K; Narayan KMV; Mohan V; Davies MJ; Yates T; Oldenburg B; Thankappan KR; Tapp RJ; Bajpai R; Anjana RM; Weber MB; Ali MK; Shaw JE
    Diabetes Care; 2023 Nov; 46(11):1903-1907. PubMed ID: 37650824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose and variation in cardiometabolic risk factors in people with high-risk HbA1c-defined prediabetes: A cross-sectional multiethnic study.
    Srivanichakorn W; Godsland IF; Thomson H; Misra S; Phisalprapa P; Charatcharoenwitthaya P; Pramyothin P; Washirasaksiri C; Snehalatha C; Ramachandran A; Alberti KGMM; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2017 Dec; 134():183-190. PubMed ID: 29074126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes of prediabetes and metabolic risk in Caucasian youths with overweight or obesity.
    Di Bonito P; Licenziati MR; Corica D; Wasniewska MG; Di Sessa A; Del Giudice EM; Morandi A; Maffeis C; Faienza MF; Mozzillo E; Calcaterra V; Franco F; Maltoni G; Valerio G
    J Endocrinol Invest; 2022 Sep; 45(9):1719-1727. PubMed ID: 35579861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
    Yip WCY; Sequeira IR; Plank LD; Poppitt SD
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29165385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of reduced β-cell function in Asian Indians with mild dysglycemia.
    Staimez LR; Weber MB; Ranjani H; Ali MK; Echouffo-Tcheugui JB; Phillips LS; Mohan V; Narayan KM
    Diabetes Care; 2013 Sep; 36(9):2772-8. PubMed ID: 23596180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
    Kosaka K; Noda M; Kuzuya T
    Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.